Gemini Therapeutics is a single‑asset company created to shepherd aldoxorubicin through registration. Backed by Even One Ventures and Dr Sant Chawla, we provide the capital and operational expertise required to bring this therapy to patients sooner.
Company builder focused on translating scientific innovation into scalable healthcare solutions. Co-founded GeneWEAVE (acquired by Roche) and Endpoint Health. First life sciences Visiting Partner at Y Combinator.
Medical oncologist with 30 + years of oncology trial leadership (ifosfamide, trabectedin, denosumab). Director of the Sarcoma Oncology Center, clinical faculty at UCLA, Cedars-Sinai, City of Hope, and the LA General Medical Center. Previously with appointments at MD Anderson and Stanford.
Entrepreneur and patient advocate. Co-founded GitLab and grew it into a publicly traded multibillion-dollar company. Established the Sijbrandij Foundation and Even One Ventures.